Should we use oral replacement for vitamin B12 deficiency as the first option of treatment?;¿Debemos utilizar la vía oral como primera opción para el tratamiento del déficit de vitamina B12?

Revista Clinica Espanola

Volumn 207, Issue 4, 2007, Pages 179-182

  Rabunal Rey R ^a   Monte Secades, R ^a   Pena Zemsch M ^a   Bal Alvaredo, M ^a   Gomez Gigirey A ^a  

^a HOSPITAL XERAL CALDE   (Spain)

Author keywords

Drug therapy; Oral administration; Vitamin B12 deficiency

Indexed keywords

CYANOCOBALAMIN; HEMOGLOBIN;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; FEMALE; FOLLOW UP; HEALTH CENTER; HUMAN; MALE; TREATMENT RESPONSE; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 34249811210     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13101846     Document Type: Article

References (15)

1. Aguirre Errasti C, Barreiro García G, Canovas Fernández A, Alonso Alonso JJ, de la Prieta López R. Estudio del déficit de cobalaminas en sujetos gastrectomizados y de edad avanzada. Rev Clin Esp. 2001;201:75-80.
2. Hernández García MT, Hernández Nieto L. Anemias megaloblásticas. En: Rodés Teixidor J, Guardia Massó J. Medicina Interna. Barcelona: Masson; 2004.
3. 12 without intrinsic factor. N Engl J Med. 1955; 253:502-6.
4. 12 without intrinsic factor. Acta Med Scand. 1968; 184:247-58.
5. 12: ¿ignoramos la evidencia? Aten Primaria. 2003;31:458.
6. Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood. 1998; 92:1191-8.
7. 12 treatment. J Intern Med. 1999; 246:237-8.
8. Savage D, Lindenbaum J. Relapses after interruption of cyanocobalamin therapy in patients with pernicious anemia. Am J Med. 1983;74:765-72.
9. 12 body stores during oral and parenteral treatment of pernicious anaemia. Acta Med Scand. 1978; 204:81-4.
10. 12 therapy in the primary care setting: a qualitative and quantitative study of patient perspectives. BMC Fam Pract. 2005;6:8.
11. 12. Am J Med Sci. 1950;220:604-9.
12. Bolaman Z, Kadikoylu G, Yukselen V, Yavasoglu I, Barutca S, Senturk T. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clin Ther. 2003; 25:3124-34.
13. 12 deficiency. Am Fam Physician. 2004;69:264.
14. 12. Med Clin (Barc). 2001;116:457-8.
15. 12 injections versus oral supplements. How much money could be saved by switching from injections to pills? Can Fam Physician. 2001;47:79-86.